Emerging Indications for Therapeutic Antibodies - Aug. 31 - Sept. 1 | Virtual

Register

Premier Sponsors

View By:

Bispecific Antibodies

Covid Interventions

Covid Interventions

Therapeutic Interventions for COVID-19

Improving Immunotherapy Efficacy and Safety

Characterization for Novel Biotherapeutics

Difficult-to-Express Proteins

Display of Biologics

Antibodies for Cancer Therapy

Advancing Bispecific Antibodies and Combination Therapy to the Clinic

Introduction to Immunogenicity

Driving Clinical Success in Antibody-Drug Conjugates

Accelerating Vaccine Development for COVID-19

CAR T, TCRs and TILS

Biophysical Methods

Engineering Antibodies

Optimizing Protein Expression

Engineering Bispecific Antibodies

Immunogenicity Assessment and Management